Heart failure & cardiomyopathiesGuideline or statement

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

CirculationPublished

  • Clinical practice guideline

Literature search September 14, 2022, to November 22, 2022 (PubMed, EMBASE, Cochrane Library, AHRQ, other databases); additional studies through May 23, 2023 considered

Scope

As issued by the authors

Management of patients with hypertrophic cardiomyopathy; updates the 2020 AHA/ACC guideline with new evidence

Original publication

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. Published 8 May 2024. doi:10.1161/cir.0000000000001250

Summarised from the published abstract; every number is checked against it